《Traditional Chinese medicine how to go global中药走向国际化英文版.doc》由会员分享，可在线阅读，更多相关《Traditional Chinese medicine how to go global中药走向国际化英文版.doc（12页珍藏版）》请在三一办公上搜索。
1、Traditional Chinese medicine how to go global1A, the present situation of the international status of Chinese medicine2Second, the disadvantages of international trade of traditional Chinese medicine2(1) the doctor of traditional Chinese medicine theory to be accepted by the foreign overall takes a
2、long time2(2) the limitation of western legal system3(3) technical barriers in international trade restrictions3Three, in traditional Chinese medicine in our country in international trade can be slightly to take the strategy3(A) flexible exploration product form, the breakthrough4(B) strengthen the
3、 patent protection, participation in international standards41 the combination of standard and intellectual property rights is a country and one of the strategic choice of economic development62 the current technical standard hinder the process of internationalization of Chinese medicine in our coun
4、try63 system of our country has (repair) book related to intellectual property rights of traditional Chinese medicine standard basic conditions74 our country intellectual property rights must be incorporated into standard strategy of traditional Chinese medicine85 in the intellectual property rights
5、 to the traditional Chinese medicine standard penetration must be fully respecting the rule of its innovation of traditional Chinese medicine8Fourth, winter has come, will spring be far away a depression will breed great business opportunities!10Century philanthropy group chairman Ren Zhijie:10Tradi
6、tional Chinese medicine how to go global Pick to: Chinas accession t o w - after the status has not improved significantly in the traditional Chinese medicine in the world, has it not hard to accepted by westerners, the original theory of Chinese medicine Because, there are some barriers to trade in
7、 international trade to overcome. To adhere to the theory of traditional Chinese medicine, therefore, under the premise of guidance, use modern technology of traditional Chinese medicine (TCM) system Medicine technology are modified, by conforming product exports to enlarge the influence of traditio
8、nal Chinese medicine in the world, at the same time pay attention to and participation in the international standard of traditional Chinese medicine patent protection Accurate formulation. Key words: traditional Chinese medicine; International trade; Product strategy A, the present situation of the
9、international status of Chinese medicine 2 0 0 1 year since joined WT O, benefited the world trade organization principle of the trade liberalization, foreign pharmaceutical trade of China is rapidly developing, especially promote the a large number of exports of Chinese medicine. According to medic
10、al and health products import and export chamber of commerce in China, according to data from 2, 1 1 0 0 0 1), Chinas traditional Chinese medicine goods trade volume reached 0. 2 $4, 600 million, 2 0%, year-on-year growth in import and export trade surplus for 9. 5 at $400 million. However, single C
11、hinese medicine export trade object, more concentrated in Asian countries, and in the pharmaceutical industry is more developed European and American countries, the export share is relatively small. At the same time, exports on primary processing in TCM products and low added value of traditional Ch
12、inese medicine is given priority to, high value in medicine is still in the bottom of proprietary Chinese medicine export. Traditional Chinese medicine in the pharmaceutical industrys status is still not changed radically. Add after the world trade organization (wto), Chinas exports of traditional C
13、hinese medicine breakthroughs like other industries, not the main reason is not received worldwide recognition of traditional Chinese medicine theory, Chinese medicine international status is still low. At present, the traditional Chinese medicine (TCM) in most countries in the world has not been le
14、gal recognition of traditional Chinese medicine workers generally without legal status, for commercial registration; Traditional Chinese medicine (TCM) in most countries belong to the category of informal medical, academic status in medical field is lower, the present domestic system of traditional
15、Chinese medicine magazine hasnt entered the United States a science citation index. Second, the disadvantages of international trade of traditional Chinese medicine (1) the doctor of traditional Chinese medicine theory to be accepted by the foreign overall takes a long time Chinese medicine theory i
16、s difficult to be different cultural tradition and philosophy of westerners understand and accept. Chinese medicine theory is the basis of Oriental philosophy, its exquisite refined, gas, god, pay attention to Yin and Yang and the five elements, exquisite, qi-blood and so on. And western medicine th
17、eory is real, tangible. Ancestors mainly in western medicine anatomy, westerners dont understand the existence of meridians. (2) the limitation of western legal system Chinese medicine into the western market, must at least to overcome two obstacles. A work permit and medical insurance risk Without
18、a work permit which is medical license, cannot be opened. In medical treatment for a period, the price does not poor, if can not be the insurance company for reimbursement of medical treatment charge, purely by the patients themselves by patients economic burden will be heavy. Western countries now
19、add to the limitation on the doctor of traditional Chinese medicine drugs, medicine market access. Western countries of market admittance threshold is very high, a medicine to enter the market, must go through several tests, and time-consuming must often for several years. And abroad on the provisio
20、ns of the pharmaceutical and healthcare products varies widely, health care products market access is much more loose. So, now in some foreign only instead of traditional Chinese medicine, to change Chinese medicine into the health care tea or in the form of other health care products into the marke
21、t. (3) technical barriers in international trade restrictions In pesticide residue analysis techniques, the United States more F D A method can detect 3 6 0 many kinds of pesticide residue detection, Germanys method can detect 3 2, 5 kinds of pesticides, Canada more method can detect 2 5 1 kind of p
22、esticide residue detection. Although some of the traditional Chinese medicine have been highly toxic pesticides, such as the 666, D, T and some organophosphorus pesticide such as 2 D four pesticides monomer for testing, but some may use in the process of Chinese medicine planting of pesticides, we a
23、lso involve very little. Involves the kinds of traditional Chinese medicines, related studies about harmful residues in China less than one hundred species of Chinese medicinal materials. Exported from customs statistics in recent years, Chinese herbal medicine for excessive harmful residues under d
24、etention and return, has become Chinas traditional Chinese medicine export and the development of traditional Chinese medicine (TCM) is an important factor. Three, in traditional Chinese medicine in our country in international trade can be slightly to take the strategy Enterprises should take contr
25、ol of your own intellectual property rights, dont repeat, some low level should be developed on behalf of the birth, I have added value, can be accepted by the overseas market of green products, establishing the new image of overseas traditional Chinese medicine (TCM) in. The state council about sup
26、port and promote the development of TCM cause several opinions put forward in the export structure optimization of Chinese medicine products improve export product added value, support Chinese enterprises to explore international market. Research and development of new drug of TCM become very import
27、ant and urgent task today. (A) flexible exploration product form, the breakthrough Develop TCM products entity, one is in the domestic market circulation proprietary Chinese medicine Chinese medicine formula is relatively simple, has a good clinical curative effect, high market share, and and used i
28、n the basic research of Chinese medicinal materials of a product, according to different countries and regions, deep research, developed by the recognition of the new medicine developed countries and regions; 2 it is to choose several refractory, western medicine of traditional Chinese medicine cura
29、tive effect is definite diseases, such as class wind wet sex arthritis, osteoporosis, cancer, AIDS, gynecopathy, disease of heart head blood-vessel, such as organization of basic and clinical traditional Chinese cooperative study, strive for breakthrough in curative effect, develop to become a world
30、 class new medicine with good prospects. Extraction is an important part of the plant medicine application and the way, have a good base for application and broad market. Production plant extracts is to improve the traditional Chinese medicinal materials and slices attached bonus is an efficient way
31、, with high technical content, high value-added and quality controllable and clear advantages such as effective ingredients, and is expected to as the bridge of traditional Chinese medicine export industry, but also provide the conditions for the development of more natural medicine products. Accord
32、ing to the forecast, in the past two years, plant extracts in China exports will continue to maintain rapid development speed, the export market will be a growing market. At present, from the Angle of market economy, traditional Chinese medicine as a pharmaceutical health care products whether can d
33、evelop the international market, mainly depending on the market competition ability. Domestic traditional Chinese medicine industry, therefore, in addition to all kinds of measures should be taken to vigorously improve the current discussion is more the efficacy of herbal medicines and proprietary C
34、hinese medicine, quality, packing, description, and export sales management problems, still should according to the foreign market demand changes, provide a variety of timely product of traditional Chinese medicine. As proprietary Chinese medicine to treat various disease, raise body health and nutr
35、itional medicine products, suitable for overseas different levels and learning needs of different families and other traditional Chinese medicine traditional Chinese medicine (TCM) teaching material, and so on. (B) strengthen the patent protection, participation in international standards Patent is
36、the modern Chinese medicine and herbal medicine market competition is the effective means to protect the brand, is the foundation of traditional Chinese medicine (TCM) industry standard drafting, who owns the standard, is the flagship of the future who will be able to perform, can occupy the strateg
37、ic high ground. China to play to the value of traditional Chinese medicine products to participate in the development of world medicine standard plants. If standards initiative in hand, will certainly have huge return on Chinese herbal medicine industry. If there are multiple products standard in Ch
38、inese hands, so that China can plants around the world medicine market. Ginkgo biloba main resources in our country, first to find its medicinal value. Ginkgo preparations continue distributes, plant medicine market in the first place, but the invention patent and the drug standards are owned by Ger
39、man companies. In the past we tend to think Chinese medicine is the treasure of the motherland, granted with intellectual property rights in our country, but in fact far from it. It is because of the lack of the core intellectual property rights, Chinas traditional Chinese medicine enterprises compe
40、ting in a weak position for a long time. Medicinal materials and Chinese medicines sliced and prepared for decoction to pharmaceutical production and business enterprises all channels and all levels of medical institutions, now the YaoShi rowed slowly, like a backwater, near the point of paralysis,
41、predominantly yinpian operating part YaoShi face reshuffle danger. And now the major national professional market of Chinese medicinal materials of self-employed business almost all did not have the pharmaceutical trade license, are illegal operation to the whole country 1 7 Chinese medicinal materi
42、als professional market are unlicensed operation state, the state food and drug administration, though a clear requirements. To ensure the legal status of Chinese medicinal materials professional market, but it is not a relevant policies or measures, the YaoShi now is half-dead, only have a sigh of
43、relief drug and YaoShi enterprises one by one words true image enough, feel said not profound enough! Embattled YaoShi when can out of the encirclement, we look forward to the related departments of a feasible way to as soon as possible, as soon as possible thaw YaoShi! In 2006, the state administra
44、tion of traditional Chinese medicine issued the standardization of Chinese medicine development plan (2006-2010) , comprehensively launched the standardization of Chinese medicine, plans to make 500 to 2010 standard of traditional Chinese medicine. It is important to the development of the industry
45、of traditional Chinese medicine is a great event. However, in todays era of knowledge economy, the standard has already developed close relations with the intellectual property rights, developed countries are through technology patent, patent standardization, standard license global technology licen
46、sing strategies, take advantage of its technical and financial advantages, weaken the advantage of products and services in developing countries, in order to make sure it can achieve maximum benefits in international trade. Therefore, in the process of standardization construction of traditional Chi
47、nese medicine in our country, must be proactive in problem combined with the development of internationalization and modernization of traditional Chinese medicine, to consciously learn to blend in intellectual property rights to the standards. With the establishment and perfection of the intellectua
48、l property system in our country, traditional Chinese medicine intellectual property rights in the field of primitive accumulation has been completed, but the existing intellectual property of traditional Chinese medicine and Chinese medicine alone standard, is difficult to meet the needs of our cou
49、ntry medicine enterprise own development. Cant cope with the effects of the domestic and foreign situation of traditional Chinese medicine industry. Therefore, urgent need a new form, that is, the combination of standard and intellectual property rights model to promote the development of traditional Chinese medicine. In the standard system of Chinese medicine in China (repair), in order how to translate into traditional Chinese medicine of traditional Ch
